Werewolf Therapeutics HOWL Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Discipline PTC Q1 2026 Earnings Strong EPS Surprise Drives Positive Market Response GENI Q1 2026 Earnings Significant EPS Miss Despite Stock Rally Gossamer Bio Q1 2026 Earnings WiderThanExpected Loss as No Revenue Generated RCI Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Higher Targa Resources Q1 2026 Earnings EPS Misses Estimates Amid Operational Strength